Joshua Reed, MBA '00, was named CFO of Aldeyra Therapeutics, Inc., a biotechnology company. Prior to joining Aldeyra, Reed served as vice president and head of finance for Bristol-Myers Squibb's U.S. and Puerto Rico operations, a $12 billion business unit.